Back to Newsroom

International Stem Cell Corporation Announces Operating Results for the Three and Nine-months ended September 30, 2016

CARLSBAD, Calif., Nov. 16, 2016 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and announced operating results for the three and nine months ended September 30, 2016.

Click here to read the full release